Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Jointown Pharmaceutical Group Co., Ltd
  6. Financials
    600998   CNE100000W45

JOINTOWN PHARMACEUTICAL GROUP CO., LTD

(600998)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 27 41426 00633 24124 65124 651-
Enterprise Value (EV)1 26 59828 38836 12527 57333 96234 739
P/E ratio 20,3x15,4x11,7x8,50x7,94x7,92x
Yield 0,68%-2,75%3,99%4,24%3,91%
Capitalization / Revenue 0,31x0,26x0,30x0,19x0,16x0,15x
EV / Revenue 0,31x0,29x0,33x0,22x0,22x0,21x
EV / EBITDA 11,7x10,0x7,36x5,92x6,44x6,00x
Price to Book 1,48x1,42x1,75x1,08x0,94x0,91x
Nbr of stocks (in thousands) 1 877 6641 837 8951 830 4461 828 7311 828 731-
Reference price (CNY) 14,614,218,213,613,613,6
Announcement Date 04/25/201904/28/202004/26/2021---
1 CNY in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 87 13699 497110 860126 423151 440164 085
EBITDA1 2 2662 8384 9094 6605 2715 790
Operating profit (EBIT)1 1 8302 3014 3523 8454 5275 101
Operating Margin 2,10%2,31%3,93%3,04%2,99%3,11%
Pre-Tax Profit (EBT)1 1 8312 3174 3343 9754 2684 420
Net income1 1 3411 7273 0752 8413 1943 199
Net margin 1,54%1,74%2,77%2,25%2,11%1,95%
EPS2 0,720,921,551,591,711,71
Dividend per Share2 0,10-0,500,540,580,53
Announcement Date 04/25/201904/28/202004/26/2021---
1 CNY in Million
2 CNY
Previous periodNext period
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2017 S1 2019 Q2 2019 Q3
Net sales1 36 22823 76624 950
EBITDA 728--
Operating profit (EBIT)1 572589340
Operating Margin 1,58%2,48%1,36%
Pre-Tax Profit (EBT)1 1 079595342
Net income1 -416275
Net margin -1,75%1,10%
EPS2 -0,220,14
Dividend per Share ---
Announcement Date 08/29/201708/26/201910/21/2019
1 CNY in Million
2 CNY
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 -2 3812 8842 9229 31010 088
Net Cash position1 816-----
Leverage (Debt / EBITDA) -0,36x0,84x0,59x0,63x1,77x1,74x
Free Cash Flow ------
ROE (Net Profit / Equities) 7,19%9,32%15,9%12,5%12,0%12,0%
Shareholders' equity1 18 64518 52519 34022 71026 70526 682
ROA (Net Profit / Asset) 2,26%2,51%4,05%3,10%3,00%-
Assets1 59 37068 92475 98491 644106 463-
Book Value Per Share2 9,849,9910,412,614,514,8
Cash Flow per Share2 0,651,471,841,921,27-
Capex1 1 8151 1751 1581 5441 686-
Capex / Sales 2,08%1,18%1,04%1,22%1,11%-
Announcement Date 04/25/201904/28/202004/26/2021---
1 CNY in Million
2 CNY
Previous periodNext period
Key data
Capitalization (CNY) 24 651 295 942
Capitalization (USD) 3 896 698 799
Net sales (CNY) 110 859 514 090
Net sales (USD) 17 545 180 997
Number of employees 28 213
Sales / Employee (CNY) 3 929 377
Sales / Employee (USD) 621 883
Free-Float 36,1%
Free-Float capitalization (CNY) 8 897 921 530
Free-Float capitalization (USD) 1 406 519 163
Avg. Exchange 20 sessions (CNY) 111 869 085
Avg. Exchange 20 sessions (USD) 17 704 961
Average Daily Capital Traded 0,45%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA